ALKS
Alkermes plc · Healthcare · Drug Manufacturers - Specialty & Generic
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 121 | +1 | 123.13M | $6.45B | +12 | −10 |
| Q1 2026 | 122 | -3 | 122.08M | $4.29B | +3 | −7 |
| Q4 2025 | 124 | +2 | 142.93M | $4.00B | +3 | — |
| Q3 2025 | 20 | -1 | 95.12M | $2.85B | — | −2 |
| Q2 2025 | 19 | +2 | 84.64M | $2.42B | +2 | — |
| Q1 2025 | 14 | 0 | 39.73M | $1.31B | — | — |
| Q4 2024 | 14 | 0 | 45.20M | $1.30B | — | — |
| Q3 2024 | 13 | +2 | 43.42M | $1.22B | +2 | — |
| Q2 2024 | 11 | — | 42.07M | $1.01B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 14.35M | — | $345.95M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 14.35M | — | $345.95M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 14.35M | — | $345.95M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 14.35M | — | $345.95M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 14.35M | — | $345.95M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 14.35M | — | $345.95M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 14.35M | — | $345.95M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 11.01M | — | $265.40M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 11.01M | — | $265.40M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 5.48M | — | $132.16M | 0.2% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (pasif) | 3.93M | — | $94.83M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (pasif) | 3.93M | — | $94.83M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | PRIMECAP Management ✦ | 3.39M | — | $81.60M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Norges Bank ✦ (pasif) | 2.13M | — | $51.31M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 803.50K | — | $19.36M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 803.50K | — | $19.36M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 803.50K | — | $19.36M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 323.14K | — | $7.79M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 323.14K | — | $7.79M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 322.21K | — | $7.77M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 242.64K | — | $5.85M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Two Sigma Investments ✦ | 78.73K | — | $1.90M | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 384 pemegang, 171.47M saham, $5.79B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 6.91K lbr · $339,967
Officer · 664 lbr · $32,969
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi